Learn More
Tert-butyl6-bromo-4-oxo-3,4-dihydro-1‘H-spiro[1,3-benzoxazine-2,4‘-pipéridine]-1‘-, Thermo Scientific™
123.00€ - 387.00€
Identifiants chimiques
CAS | 690632-05-4 |
---|---|
Formule moléculaire | C17H21BrN2O4 |
Poids moléculaire (g/mol) | 397.269 |
Numéro MDL | MFCD05865135 |
Clé InChI | FKBBJWUNJKLMBK-UHFFFAOYSA-N |
Synonyme | tert-butyl 6-bromo-4-oxo-3,4-dihydro-1'h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, tert-butyl 6-bromo-4-oxo-3,4-dihydrospiro benzo e 1,3 oxazine-2,4'-piperidine-1'-carboxylate, 6-bromospiro 1,3-benzoxazine-2,4'-piperidine-4 3h-one, n-boc protected, tert-butyl 6-bromo-4-oxo-3h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, tert-butyl 6-bromo-4-oxospiro 3h-1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, 6-bromo-3,4-dihydro-4-oxo-spiro 2h-1,3-benzoxazine-2,4'-piperidin-1'-carboxylic acid tert-butyl ester, spiro 2h-1,3-benzoxazine-2,4'-piperidine-1'-carboxylicacid,6-bromo-3,4-dihydro-4-oxo-,1,1-dimethylethyl ester, tert-butyl 6-bromo-3,4-dihydro-4-oxo-1'h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate |
CID PubChem | 2794762 |
Nom IUPAC | tert-butyl 6-bromo-4-oxospiro[3H-1,3-benzoxazine-2,4’-pipéridine]-1’-carboxylate |
SMILES | CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)C3=C(O2)C=CC(=C3)Br |
Code produit | Marque | Quantité | Conditionnement | Prix | Quantité et disponibilité | ||||
---|---|---|---|---|---|---|---|---|---|
Code produit | Marque | Quantité | Conditionnement | Prix | Quantité et disponibilité | ||||
10451453
|
Thermo Scientific Maybridge
MO07057CB |
250 mg | Flacon en verre ambré |
123.00€
250mg |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | ||||
10317112
|
Thermo Scientific Maybridge
MO07057DA |
1 g | Flacon en verre ambré |
387.00€
1g |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | ||||
Description
Identifiants chimiques
690632-05-4 | |
397.269 | |
FKBBJWUNJKLMBK-UHFFFAOYSA-N | |
2794762 | |
CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)C3=C(O2)C=CC(=C3)Br |
C17H21BrN2O4 | |
MFCD05865135 | |
tert-butyl 6-bromo-4-oxo-3,4-dihydro-1'h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, tert-butyl 6-bromo-4-oxo-3,4-dihydrospiro benzo e 1,3 oxazine-2,4'-piperidine-1'-carboxylate, 6-bromospiro 1,3-benzoxazine-2,4'-piperidine-4 3h-one, n-boc protected, tert-butyl 6-bromo-4-oxo-3h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, tert-butyl 6-bromo-4-oxospiro 3h-1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, 6-bromo-3,4-dihydro-4-oxo-spiro 2h-1,3-benzoxazine-2,4'-piperidin-1'-carboxylic acid tert-butyl ester, spiro 2h-1,3-benzoxazine-2,4'-piperidine-1'-carboxylicacid,6-bromo-3,4-dihydro-4-oxo-,1,1-dimethylethyl ester, tert-butyl 6-bromo-3,4-dihydro-4-oxo-1'h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate | |
tert-butyl 6-bromo-4-oxospiro[3H-1,3-benzoxazine-2,4’-pipéridine]-1’-carboxylate |
Spécification
tert-Butyl 6-bromo-4-oxo-3,4-dihydro-1';H-spiro[1,3-benzoxazine-2,4';-piperidine]-1';-carboxylate | |
95.0 | |
C17H21BrN2O4 | |
tert-butyl 6-bromo-4-oxo-3,4-dihydro-1'h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, tert-butyl 6-bromo-4-oxo-3,4-dihydrospiro benzo e 1,3 oxazine-2,4'-piperidine-1'-carboxylate, 6-bromospiro 1,3-benzoxazine-2,4'-piperidine-4 3h-one, n-boc protected, tert-butyl 6-bromo-4-oxo-3h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, tert-butyl 6-bromo-4-oxospiro 3h-1,3-benzoxazine-2,4'-piperidine-1'-carboxylate, 6-bromo-3,4-dihydro-4-oxo-spiro 2h-1,3-benzoxazine-2,4'-piperidin-1'-carboxylic acid tert-butyl ester, spiro 2h-1,3-benzoxazine-2,4'-piperidine-1'-carboxylicacid,6-bromo-3,4-dihydro-4-oxo-,1,1-dimethylethyl ester, tert-butyl 6-bromo-3,4-dihydro-4-oxo-1'h-spiro 1,3-benzoxazine-2,4'-piperidine-1'-carboxylate | |
CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)C3=C(O2)C=CC(=C3)Br | |
397.269 | |
397.27 |
690632-05-4 | |
95% | |
MFCD05865135 | |
FKBBJWUNJKLMBK-UHFFFAOYSA-N | |
tert-butyl 6-bromo-4-oxospiro[3H-1,3-benzoxazine-2,4’-pipéridine]-1’-carboxylate | |
2794762 | |
95% |
Sécurité et traitement
Déclaration GHS H :
Provoque de graves lésions des yeux.
Provoque des brûlures de la peau et de graves lésions des yeux.
GHS P Statement:
IF SWALLOWED: rinse mouth. Do NOT induce vomiting.
Wear eye protection/face protection.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Immediately call a POISON CENTER or doctor/physician.
WARNING: The information provided on this web site was developed in compliance with European Union (EU) regulations and is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling and use. It is not to be considered as either a warranty or quality specification.
Mention d’avertissement GHS :danger